Viseon, Inc. Announces First US Clinical Use of the Voyant System for Minimally Invasive Spine Surgery Access, Illumination and Visualization

IRVINE, Calif.–(BUSINESS WIRE)–Viseon, Inc. today announced the first U.S. clinical human use of the Voyant System for Minimally Invasive Spine Surgery access, illumination and visualization. The case was performed by Neurosurgeon John J. Knightly, MD of the Atlantic NeuroSurgical Specialists in Morristown, New Jersey. The Voyant System is composed of a sterile single-use, disposable retractor device with integrated state-of-the-art visualization technology. The system utilizes a reusable controller enabling digital intraoperative manipulation of the surgical site image, which is displayed on operating room HD flat-panel display monitors. The sterile device also allows the surgeon to adjust intraoperative depth of focus.

Dr. John J. Knightly, Vice Chair of Neurosciences and Medical Director of the NeuroSpine Program at Overlook Medical Center’s Atlantic Neuroscience Institute in Summit, NJ, stated, “The Viseon technology has the potential to significantly change how I perform minimally invasive spinal surgery procedures. The technology represents a compelling alternative for using a surgical microscope, with sufficient anatomical distinction and depth perception to safely perform these cases, in an easy to use, disposable system.”

Viseon President and CEO Jeffrey Valko stated, “We are grateful that Dr. Knightly has pioneered our first U.S. human case, demonstrating the procedural transition from surgical microscopes. Further, he confirmed the ergonomic and efficiency advantages of this innovative system.”

Viseon previously announced FDA 510k clearance of the Voyant System in October 2018 and is currently available in the U.S. on a limited basis.

About Viseon, Inc.

Viseon has developed a platform technology that has multiple opportunities for technological expansion, including wireless, neuro-monitoring and navigation, fluorescence, sensor integration and complementary robotic applications. The company has demonstrated clinical utility in posterior lumbar decompression and interbody fusion procedures and is expanding into lumbar lateral access and anterior cervical decompression fusion applications. The privately held medical device company is located in Irvine, California, founded in 2017, and recently completed an oversubscribed follow-on financing in October 2018.

For further information, please visit www.viseon-spine.com.